Table 4. [Recommended Surveillance for Individuals with Gabriele-de Vries Syndrome]. - GeneReviews®

System/Concern	Evaluation	Frequency
Constitutional	Measurement of growth parameters	At each visit until adulthood
At each visit beginning in childhood	Monitor those w/seizures	As clinically indicated
Assessment of neurologic disease progression
Psychiatric	Behavioral assessment for anxiety, attention, & aggressive or self-injurious behavior
Ophthalmologic	Ophthalmologic evaluation	As needed based on symptoms
Miscellaneous/ Other	Monitor developmental progress & educational needs	At each visit

GeneReviews^® [Internet].

Adam MP, Feldman J, Mirzaa GM, et al., editors.

Seattle (WA): University of Washington, Seattle; 1993-2024.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.